← Back to Search

Integrated Strategy for PrEP Uptake in HIV Prevention

N/A

Waitlist Available

Research Sponsored by HIV Prevention Trials Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-report a lifetime history of sex with other men

Are at least 15 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured with data available at the end of the three year intervention

Awards & highlights

Study Summary

This trial is designed to see if an integrated strategy approach can increase uptake and use of pre-exposure prophylaxis (PrEP) and viral suppression rates among Black MSM in the southern United States.

Who is the study for?

This trial is for Black men, including cisgender and transgender, who have had sexual relations with other men. Participants must be at least 15 years old, live in the study area, and consent to a questionnaire and blood tests. HIV status doesn't matter for joining.Check my eligibility

What is being tested?

The study is testing an approach that combines health equity efforts, stigma reduction strategies, standard care enhancements, social media influencer involvement, and peer support to improve PrEP use and viral suppression among Black MSM in the South.See study design

What are the potential side effects?

Since this trial focuses on community-based interventions rather than medications or medical procedures directly administered to participants, specific side effects are not anticipated as part of the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had sexual relations with other men in my lifetime.

Select...

I am 15 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured with data available at the end of the three year intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured with data available at the end of the three year intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured with data available at the end of the three year intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PrEP use by Black MSM not living with HIV

Viral suppression in Black MSM living with diagnosed HIV

Secondary outcome measures

Care quality of Black MSM needs at HCFs participating in CRISP

Compare barriers to healthcare in Black MSM in the intervention to the SOC communities

Compare individual agency in Black MSM in the intervention to the SOC communities

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard-of-careExperimental Treatment1 Intervention

Black MSM living in standard-of-care communities will have access to standard HIV prevention and care services available in their communities.

Group II: Integrated StrategyExperimental Treatment4 Interventions

Black MSM living in intervention communities will have access to the HPTN 096 integrated strategy in addition to standard HIV prevention and care services available in their communities. The integrated strategy includes a combination of four community-, organizational-, and interpersonal-level components designed to impact individual-level outcomes.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Peer Support

2011

N/A

~4780

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

HIV Prevention Trials NetworkLead Sponsor

30 Previous Clinical Trials

563,904 Total Patients Enrolled

Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)UNKNOWN

1 Previous Clinical Trials

250 Total Patients Enrolled

LaRon Nelson, PhDStudy ChairYale University

1 Previous Clinical Trials

549 Total Patients Enrolled

Media Library

Health Equity Clinical Trial Eligibility Overview. Trial Name: NCT05075967 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Standard-of-care, Integrated Strategy

Human Immunodeficiency Virus Infection Clinical Trial 2023: Health Equity Highlights & Side Effects. Trial Name: NCT05075967 — N/A

Health Equity 2023 Treatment Timeline for Medical Study. Trial Name: NCT05075967 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of the current research in regards to participants?

"Affirmative. According to clinicaltrials.gov, this medical trial first opened on May 14th 2022 and is currently recruiting patients for participation. There are 4800 spots available at a single site."

Answered by AI

Is access to this trial available for those seeking treatment?

"Accurately, clinicaltrials.gov documents demonstrate that this medical study is presently seeking participants. The research was first published on May 14th 2022 and has been revised recently on August 25th 2022. A total of 4800 patients must be recruited from a single site for the trial to commence."

Answered by AI

What aims is this research trying to fulfil?

"This three year trial seeks to measure the uptake of Prep amongst Black MSM who are not living with HIV six months after its conclusion. Secondary endpoints include quantifying intersectional stigma, social support and individual agency in Black MSM compared to those within the SOC communities through post-implementation cross-sectional assessment surveys."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Getting to Zero Among Black MSM in the American South

2022. "Getting to Zero Among Black MSM in the American South". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05075967.

All > Hiv Infection